PubMed:32159237 / 981-1043 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T31","span":{"begin":9,"end":19},"obj":"SP_7"},{"id":"T32","span":{"begin":44,"end":50},"obj":"SO:0000360"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines."}

{"project":"LitCovid-PAS-Enju","denotations":[{"id":"EnjuParser_T176","span":{"begin":0,"end":7},"obj":"NNS"},{"id":"EnjuParser_T177","span":{"begin":7,"end":8},"obj":"-COLON-"},{"id":"EnjuParser_T178","span":{"begin":9,"end":19},"obj":"NN"},{"id":"EnjuParser_T179","span":{"begin":20,"end":27},"obj":"VBZ"},{"id":"EnjuParser_T180","span":{"begin":28,"end":38},"obj":"NN"},{"id":"EnjuParser_T181","span":{"begin":39,"end":43},"obj":"JJ"},{"id":"EnjuParser_T182","span":{"begin":44,"end":50},"obj":"NNS"},{"id":"EnjuParser_T183","span":{"begin":51,"end":53},"obj":"TO"},{"id":"EnjuParser_T184","span":{"begin":54,"end":61},"obj":"NNS"}],"relations":[{"id":"EnjuParser_R173","pred":"arg1Of","subj":"EnjuParser_T176","obj":"EnjuParser_T177"},{"id":"EnjuParser_R174","pred":"arg2Of","subj":"EnjuParser_T179","obj":"EnjuParser_T177"},{"id":"EnjuParser_R175","pred":"arg1Of","subj":"EnjuParser_T178","obj":"EnjuParser_T179"},{"id":"EnjuParser_R176","pred":"arg2Of","subj":"EnjuParser_T182","obj":"EnjuParser_T179"},{"id":"EnjuParser_R177","pred":"arg1Of","subj":"EnjuParser_T182","obj":"EnjuParser_T180"},{"id":"EnjuParser_R178","pred":"arg1Of","subj":"EnjuParser_T182","obj":"EnjuParser_T181"},{"id":"EnjuParser_R179","pred":"arg1Of","subj":"EnjuParser_T182","obj":"EnjuParser_T183"},{"id":"EnjuParser_R180","pred":"arg2Of","subj":"EnjuParser_T184","obj":"EnjuParser_T183"}],"text":"RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines."}

{"project":"LitCovid-ArguminSci","denotations":[{"id":"T5","span":{"begin":0,"end":62},"obj":"DRI_Background"}],"text":"RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines."}

{"project":"LitCovid-OGER","denotations":[{"id":"T11","span":{"begin":9,"end":13},"obj":"PR:000014459"},{"id":"T12","span":{"begin":44,"end":50},"obj":"SO:0000360"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":62},"obj":"Sentence"}],"text":"RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines."}

{"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T11","span":{"begin":9,"end":17},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines."}

{"project":"LitCovid-PD-FMA-UBERON-v1","denotations":[{"id":"T6","span":{"begin":28,"end":38},"obj":"Body_part"},{"id":"T7","span":{"begin":54,"end":61},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma82773"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma82772"}],"text":"RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok187","span":{"begin":0,"end":7},"obj":"NNP"},{"id":"tok188","span":{"begin":7,"end":8},"obj":":"},{"id":"tok189","span":{"begin":9,"end":18},"obj":"NNP"},{"id":"tok190","span":{"begin":18,"end":19},"obj":"CD"},{"id":"tok191","span":{"begin":20,"end":27},"obj":"VBZ"},{"id":"tok192","span":{"begin":28,"end":38},"obj":"NN"},{"id":"tok193","span":{"begin":39,"end":43},"obj":"JJ"},{"id":"tok194","span":{"begin":44,"end":50},"obj":"NNS"},{"id":"tok195","span":{"begin":51,"end":53},"obj":"TO"},{"id":"tok196","span":{"begin":54,"end":61},"obj":"NNS"},{"id":"tok197","span":{"begin":61,"end":62},"obj":"."},{"id":"lookup25","span":{"begin":51,"end":53},"obj":"country_code"}],"text":"RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines."}